BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 10217367)

  • 1. C4 null alleles and myocardial infarction.
    Nityanand S; Hamsten A; Lithell H; Holm G; Lefvert AK
    Atherosclerosis; 1999 Apr; 143(2):377-81. PubMed ID: 10217367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating immune complexes and complement C4 null alleles in patients in patients operated on for premature atherosclerotic peripheral vascular disease.
    Nityanand S; Truedsson L; Mustafa A; Bergmark C; Lefvert AK
    J Clin Immunol; 1999 Nov; 19(6):406-13. PubMed ID: 10634214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular heterogeneity of second and fourth components of complement and their genes in systemic sclerosis and association of HLA alleles A1, B8 and DR3 with limited and DR5 with diffuse systemic sclerosis.
    Venneker GT; van den Hoogen FH; van Meegen M; de Kok-Nazaruk M; Hulsmans RF; Boerbooms AM; de Waal LP; Bos JD; Asghar SS
    Exp Clin Immunogenet; 1998; 15(2):90-9. PubMed ID: 9691203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between circulating immune complexes, complement C4 null alleles, and myocardial infarction before age 45 years.
    Lefvert AK; Hamsten A; Holm G
    Arterioscler Thromb Vasc Biol; 1995 May; 15(5):665-8. PubMed ID: 7749879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular heterogeneity of the fourth component of complement (C4) and its genes in vitiligo.
    Venneker GT; Westerhof W; de Vries IJ; Drayer NM; Wolthers BG; de Waal LP; Bos JD; Asghar SS
    J Invest Dermatol; 1992 Dec; 99(6):853-8. PubMed ID: 1469300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A unique recombination event resulting in a C4A*Q0,C4B*Q0 double null haplotype.
    Fasano MB; Winkelstein JA; LaRosa T; Bias WB; McLean RH
    J Clin Invest; 1992 Oct; 90(4):1180-4. PubMed ID: 1401055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C4 null alleles in childhood onset systemic lupus erythematosus. Is there any relationship with renal disease?
    Clemenceau S; Castellano F; Montes de Oca M; Kaplan C; Danon F; Levy M
    Pediatr Nephrol; 1990 May; 4(3):207-12. PubMed ID: 2400645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of C4 null alleles on C4 activation in systemic lupus erythematosus.
    Briggs DC; Senaldi G; Isenberg DA; Welsh KI; Vergani D
    Ann Rheum Dis; 1991 Apr; 50(4):251-4. PubMed ID: 2029208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphism of the fourth component of complement in Turks.
    Metin A; Sanal O; Ersoy F; Tezcan I; Berkel AI; IrkeƧ C
    Hum Biol; 2000 Jun; 72(3):527-33. PubMed ID: 10885198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined heterozygous deficiency of the classical complement pathway proteins C2 and C4.
    Hartmann D; Fremeaux-Bacchi V; Weiss L; Meyer A; Blouin J; Hauptmann G; Kazatchkine M; Uring-Lambert B
    J Clin Immunol; 1997 Mar; 17(2):176-84. PubMed ID: 9083894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inherited deficiency of the fourth component of human complement.
    Hauptmann G; Tappeiner G; Schifferli JA
    Immunodefic Rev; 1988; 1(1):3-22. PubMed ID: 3078708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of C4B deficiency (C4B*Q0) with erythema nodosum in leprosy.
    de Messias IJ; Santamaria J; Brenden M; Reis A; Mauff G
    Clin Exp Immunol; 1993 May; 92(2):284-7. PubMed ID: 8485914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Class III alleles and high-risk MHC haplotypes in type I diabetes mellitus, Graves' disease and Hashimoto's thyroiditis.
    Skanes VM; Barnard J; Farid N; Marshall WH; Murphy L; Rideout D; Taylor R; Xidos G; Larsen B
    Mol Biol Med; 1986 Apr; 3(2):143-57. PubMed ID: 3461234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regional variation in C4 phenotype in patients with IgA nephropathy.
    Wyatt RJ; Rivas ML; Schena FP; Bin JA; Julian BA
    J Pediatr; 1990 May; 116(5):S72-7. PubMed ID: 2329414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incomplete functional deficiencies of the fourth (C4) and second (C2) components of complement in a patient with linear frontoparietal scleroderma and his family. Deficiencies determined by a gene not linked to human leukocyte antigen system.
    Venneker GT; van Meegen M; de Kok-Nazaruk M; Hulsmans RF; de Waall LP; Bos JD; Asghar SS
    Exp Clin Immunogenet; 1996; 13(2):104-11. PubMed ID: 9063702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of complement component C4 copy number variation in human longevity.
    Flachsbart F; Caliebe A; Heinsen FA; Hemming-Karlsen T; Schreiber S; Franke A; Nebel A
    PLoS One; 2014; 9(1):e86188. PubMed ID: 24465950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneity in the structural basis of the human complement C4A null allele (C4A Q0) as revealed by HindIII restriction fragment length polymorphism analysis.
    Uring-Lambert B; Vegnaduzzi N; Carroll MC; Tongio MM; Goetz J; Hauptmann G
    FEBS Lett; 1987 Jun; 217(1):65-8. PubMed ID: 2885219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An estimate on the frequency of duplicated haplotypes and silent alleles of human C4 protein polymorphism. II. Investigations in healthy Negro families.
    Steuer MK; Oudshoorn M; Brenden M; Fimmers R; Neugebauer M; du Toit E; Baur MP; Mauff G
    Tissue Antigens; 1994 Feb; 43(2):88-94. PubMed ID: 8016847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reference typing report for complement component C4.
    Mauff G; Luther B; Schneider PM; Rittner C; Stradmann-Bellinghausen B; Dawkins R; Moulds JM
    Exp Clin Immunogenet; 1998; 15(4):249-60. PubMed ID: 10072635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neonatal lupus erythematosus syndrome: analysis of C4 allotypes and C4 genes in 18 families.
    Watson RM; Scheel JN; Petri M; Lee LA; Bias WB; McLean RH
    Medicine (Baltimore); 1992 Mar; 71(2):84-95. PubMed ID: 1545698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.